These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital. Ye Y; Li JB; Ye DQ; Jiang ZJ Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia. Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126 [TBL] [Abstract][Full Text] [Related]
4. Enterobacter bacteremia in the community hospital. Haddy RI; Cecil ML; Norris LL; Markert RJ J Fam Pract; 1991 Jun; 32(6):601-6. PubMed ID: 2040885 [TBL] [Abstract][Full Text] [Related]
6. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813 [TBL] [Abstract][Full Text] [Related]
7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of critically ill patients with bacteremia]. Du B; Chen D; Li H Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):416-9. PubMed ID: 10923501 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer. Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352 [TBL] [Abstract][Full Text] [Related]
11. Enterobacter aerogenes primary bacteremia in pediatric patients. Edwards KE; Allen JR; Miller MJ; Yogev R; Hoffman PC; Klotz R; Marubio S; Burkholder E; Williams T; Davis AT Pediatrics; 1978 Sep; 62(3):304-6. PubMed ID: 704200 [TBL] [Abstract][Full Text] [Related]
12. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909 [TBL] [Abstract][Full Text] [Related]
13. [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors]. Peña C; Pujol M; Pallarés R; Cisnal M; Ariza J; Gudiol F Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):424-8. PubMed ID: 8260514 [TBL] [Abstract][Full Text] [Related]
14. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750 [TBL] [Abstract][Full Text] [Related]
15. Enterobacter cloacae bacteremia in children: a review of 30 cases in 12 years. Bonadio WA; Margolis D; Tovar M Clin Pediatr (Phila); 1991 May; 30(5):310-3. PubMed ID: 2044341 [TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital. Choi HK; Kim YK; Kim HY; Park JE; Uh Y Korean J Intern Med; 2015 Mar; 30(2):219-25. PubMed ID: 25750564 [TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of Enterobacter bacteremia in pediatric patients: a 10-year study. Chen HL; Lu JH; Wang HH; Chen SJ; Chen CJ; Wu KG; Tang RB J Microbiol Immunol Infect; 2014 Oct; 47(5):381-6. PubMed ID: 23773708 [TBL] [Abstract][Full Text] [Related]